Macerich is a fully integrated, self-managed, and self-administered real estate investment trust (REIT). As a leading owner, operator and developer of high-quality retail real estate in densely populated and attractive U.S. markets, Macerich's portfolio is concentrated in California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, D.C. corridor. Developing and managing properties that serve as community cornerstones, Macerich currently owns 45 million square feet of real estate consisting primarily of interests in 41 retail centers. Macerich is firmly dedicated to advancing environmental goals, social good and sound corporate governance. A recognized leader in sustainability, Macerich has achieved a #1 Global Real Estate Sustainability Benchmark (GRESB) ranking for the North American retail sector for ten consecutive years (2015-2024).

The Macerich Company

In a report released yesterday, Matthew Caufield from H.C. Wainwright maintained a Buy rating on Diamedica Therapeutics, with a price target of $12...

H.C. Wainwright Keeps Their Buy Rating on Diamedica Therapeutics (DMAC)

Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Macerich (MAC), American Homes (AMH) and InvenTru...

Analysts’ Opinions Are Mixed on These Real Estate Stocks: Macerich (MAC), American Homes (AMH) and InvenTrust Properties (IVT)

Berenberg Bank analyst Michael Heider reiterated a Hold rating on Macfarlane today and set a price target of p82.00. According to TipRanks, Heider ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MAC	$22.67	-0.57%	2.50M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MAC	$22.67	-0.6%	2.50M
3
4
5
6

MAC

Get The Macerich Company Data in Excel

Get The Macerich Company Data in Excel